EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Blue Water Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing July 31, 2025 GREENWICH, Conn., July 28, 2025 - Blue Water Acquisition Corp. III (Nasdaq: BLUWU) (the “Company”) today announced that, commencing July 31, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on The Nasdaq Global Market under the symbols “BLUW” and “BLUWW,” respectively. Those units not separated will continue to trade on The Nasdaq Global Market under the symbol “BLUWU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants. The offering of the units was made only by means of a prospectus, copies of which may be obtained from BTIG, LLC, 65 East 55th Street, Ne…
Open exhibit ↗Current Report · Items 8.01, 9.01 · 8-K
Blue Water Acquisition Corp. III
BLUWNASDAQEQUITYCurrent
Other Events
Item 8.01. Other Events. On July 28, 2025, Blue Water Acquisition Corp. III (the “Company”) announced that, on or about July 31, 2025, the holders of the Company’s units (the “Units”) may elect to separately trade the Class A ordinary shares and warrants included in the Units. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant.…
Company context
We are a blank check company incorporated on November 1, 2024 as a Cayman Islands exempted company with no material operations of our own and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on high-potential companies in the biotechnology, healthcare and technology sectors. Our mission is to leverage our management team’s extensive expertise and deep industry connections to drive transformative advancements and generate substantial returns for our investors.